Rare but deadly manifestation of systemic lupus erythematosus

BMJ Case Rep. 2020 Nov 2;13(11):e239646. doi: 10.1136/bcr-2020-239646.

Authors

Sebastian Alejandro Mikulic¹, Michael Chahin², Sukhraj Singh³, Myint Thway³

Affiliations

¹ Internal Medicine, University of Florida College of Medicine, Jacksonville, Florida, USA [email protected].
² Internal Medicine, University of Florida College of Medicine, Jacksonville, Florida, USA.
³ Department of Medicine Division of Rheumatology, UF Health Jacksonville, Jacksonville, Florida, USA.

No abstract available

Keywords: Drugs: musculoskeletal and joint diseases; systemic lupus erythematosus.

Publication types

Case Reports

MeSH terms

Administration, Intravenous
Adult
Antirheumatic Agents / administration & dosage
Antirheumatic Agents / therapeutic use
Black or African American / ethnology
Bronchoalveolar Lavage / methods
Bronchoscopy / methods
Female
Glucocorticoids / administration & dosage
Glucocorticoids / therapeutic use
Hemorrhage / drug therapy
Hemorrhage / etiology*
Humans
Hypoxia / etiology
Kidney Failure, Chronic / etiology*
Lupus Erythematosus, Systemic / complications*
Methylprednisolone / administration & dosage
Methylprednisolone / therapeutic use
Pulmonary Alveoli / blood supply
Pulmonary Alveoli / diagnostic imaging
Pulmonary Alveoli / pathology*
Radiography, Thoracic / methods
Rituximab / administration & dosage
Rituximab / therapeutic use
Treatment Outcome

Substances

Antirheumatic Agents
Glucocorticoids
Rituximab
Methylprednisolone